Janet D. Culshaw

Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation

Malcolm Anderson, John F. Beattie, Gloria A. Breault et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 114 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +12

Imidazo[1,2- a ]pyridines. Part 2 : SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors

Kate F. Byth, Janet D. Culshaw, Stephen Green et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 113 citations · Full text

Pharmacy, Medicinal Chemistry, Drug Design +13

Imidazo[1,2- b ]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors

Kate F. Byth, Nicola J. Cooper, Janet D. Culshaw et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 73 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88^L265P Diffuse Large B-Cell Lymphoma

James S. Scott, Sébastien L. Degorce, Rana Anjum et al. · Journal of Medicinal Chemistry · 2017 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +10

Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors

Malcolm Anderson, David Andrews, Andy Barker et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 30 citations · Full text

Pharmacy, Chemical Biology, Medicinal Chemistry +10